A study on myeloproliferative neoplasms (MPN) revealed that the CC genotype of IFNL3 rs12979860 was significantly associated with hematologic response to interferon‐α treatment, with a significantly higher complete response rate compared with non‐CC.68 This evidence concerns the gene IFNL3 and myeloproliferative neoplasm.